Screening, Evaluation and Diagnosis of Substance Use Disorders

In this presentation, we review assessment tasks---screening, evaluation, and diagnosis--- and how they inform addiction treatment. Particularly, we will discuss recommended instruments for screening and multidimensional evaluation and their roles in the management of substance use disorders. 

Antoine Douaihy, MD

Antoine Douaihy, MD

Professor of Psychiatry & Medicine, University of Pittsburgh School of Medicine

Dr. Douaihy is a Professor of Psychiatry and Medicine, Senior Academic Director of Addiction Medicine Services (AMS) and Addiction Psychiatry Fellowship at Western Psychiatric Hospital of the University of Pittsburgh Medical Center (UPMC), and Co-Director of the Tobacco Treatment Service of UPMC. His areas of clinical and research expertise and interest are substance use disorders (SUDs) and SUDs co-occurring with psychiatric disorders in adults and adolescents, psychiatric disorders in individuals with HIV/HCV, smoking cessation and psychosocial approaches, particularly motivational interviewing, and medication trials for co-occurring disorders, opioid and stimulant use disorders. He has a demonstrated record of expertise and experience in SUDs and a well established record of leadership and expertise in conducting multi-site clinical trials. He has served as Principal Investigator (PI), Co-I, or a consultant on studies funded by NIAAA, NIDA, NIMH, SAMHSA, and pharmaceutical industries. He served as a member of the Opioid Addiction Task Force (established in the U.S. District Attorney in Allegheny County) and the opioid addiction and recovery task force at the University of Pittsburgh. He is currently the vice chair of Pittsburgh HIV/AIDS Commission and a member of the physician work group on medical marijuana at the PA Department of Health.

Components visible upon registration.